Scholarlink

<p>We present a 48-year-old woman with moderate refractory plaque psoriasis and lupus erythematosus tumidus (LET) who experienced rapid LET improvement and significant psoriasis response under deucravacitinib 6 mg/day. This case highlights the possible role of tyrosine kinase 2 (TYK2) inhibition with deucravacitinib in the treatment of LET.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Erfolgreiche Behandlung eines Lupus erythematodes tumidus (LET) mit Deucravacitinib bei einer Patientin mit gleichzeitig vorliegender Plaquepsoriasis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月2日

查看全文
  • Tim Schricker,
  • Antonia Matiszick,
  • Ulrike Raap,
  • Nikolaos Patsinakidis

摘要

We present a 48-year-old woman with moderate refractory plaque psoriasis and lupus erythematosus tumidus (LET) who experienced rapid LET improvement and significant psoriasis response under deucravacitinib 6 mg/day. This case highlights the possible role of tyrosine kinase 2 (TYK2) inhibition with deucravacitinib in the treatment of LET.